Hypertensive disorders of pregnancy (HDP) are the most common medical complication
of pregnancy, affecting about 10% of pregnancies.1 They are still a leading cause of maternal and perinatal mortality worldwide. As
a consequence, antenatal care is devoted in large part to their detection and prediction.
Risk factors for HDP are related to clinical epidemiological, hemodynamic, and basic
biochemical factors. For example, combining clinical maternal risk markers, placental
growth factor and uterine artery pulsatility index in the first trimester has sensitivities
of 75% for preterm preeclampsia and 47% for term preeclampsia, compared with sensitivities
of 34% and 39%, respectively, for use of clinical risk markers alone.2
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & Gynecology MFMAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
December 15,
2022
Received:
December 4,
2022
Publication stage
In Press Accepted ManuscriptFootnotes
Conflicts of interest: The authors report no conflict of interest.
Financial support: None.
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.
